Epigenetic therapies are offering a more targeted way to treat some lymphomas by changing how genes are turned on or off ...

Mantle-cell lymphoma accounts for approximately 5 to 7% of all lymphomas, and in North America and Europe, the frequency is similar to that of noncutaneous, peripheral T-cell lymphomas. The median age ...

In equatorial Africa, a region of the globe known as the "lymphoma belt," children are ten times more likely than in other parts of the world to develop Burkitt's lymphoma, a highly aggressive blood ...

Low-grade lymphomas are a non-Hodgkin lymphoma (NHL) subtype. They typically grow more slowly and cause fewer symptoms than NHLs. They still require ongoing monitoring and treatment. There are two ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Low grade lymphomas are non-Hodgkin lymphoma (NHL) that grow slowly and are often asymptomatic compared with other types of NHL. However, they may still require ongoing monitoring and treatment. There ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...

Recent news reveals Full House star Dave Coulier is battling stage 3 lymphoma, drawing attention and concern from fans worldwide. Many are eager to learn what led to his diagnosis, the treatments he’s ...

The lymphatic system is the network of vessels, tissues, and organs that are part of the body’s immune system. Lymphoma develops in infection-fighting cells called lymphocytes that circulate through ...

Being treated for Hodgkin lymphoma during childhood can result in fertility declines, a recent study shows. Pregnancy after cancer treatment can come with complications for a patient with Hodgkin ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...